CMA moved below its 50-day moving average on December 17, 2024 date and that indicates a change from an upward trend to a downward trend. In of 37 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 70 cases where CMA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The 10-day moving average for CMA crossed bearishly below the 50-day moving average on December 19, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CMA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for CMA entered a downward trend on January 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CMA's RSI Indicator exited the oversold zone, of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on January 03, 2025. You may want to consider a long position or call options on CMA as a result. In of 100 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for CMA just turned positive on January 07, 2025. Looking at past instances where CMA's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CMA advanced for three days, in of 293 cases, the price rose further within the following month. The odds of a continued upward trend are .
CMA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CMA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.192) is normal, around the industry mean (1.030). P/E Ratio (8.402) is within average values for comparable stocks, (18.662). Projected Growth (PEG Ratio) (0.310) is also within normal values, averaging (2.366). Dividend Yield (0.052) settles around the average of (0.058) among similar stocks. P/S Ratio (2.004) is also within normal values, averaging (2.921).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CMA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 66, placing this stock worse than average.
a major bank
Industry RegionalBanks
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
NVD | 30.41 | 0.61 | +2.05% |
GraniteShares 2x Short NVDA Daily ETF | |||
HLGE | 31.30 | 0.15 | +0.47% |
Hartford Longevity Economy ETF | |||
JIRE | 58.30 | 0.26 | +0.45% |
JPMorgan International Rsrch Enh Eq ETF | |||
PHYL | 34.75 | 0.06 | +0.19% |
PGIM Active High Yield Bond ETF | |||
MMIT | 23.93 | N/A | N/A |
NYLI MacKay Muni Intermediate ETF |
A.I.dvisor indicates that over the last year, CMA has been closely correlated with ZION. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if CMA jumps, then ZION could also see price increases.
Ticker / NAME | Correlation To CMA | 1D Price Change % | ||
---|---|---|---|---|
CMA | 100% | +3.45% | ||
ZION - CMA | 81% Closely correlated | +3.92% | ||
ABCB - CMA | 78% Closely correlated | +4.54% | ||
PNFP - CMA | 78% Closely correlated | +4.36% | ||
OCFC - CMA | 77% Closely correlated | +2.56% | ||
RF - CMA | 77% Closely correlated | +1.61% | ||
More |